暨通知债权人的公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 证券代码： 300775 证券简称： 三角防务 公告编号： 2025-070 债券代码： 123114 债券简称：三角转债 西安三角防务股份有限公司 一、通知债权人的原由 关于回购注销部分限制性股票减少注册资本 根据公司《2022年限制性股票激励计划（草案修订稿）》（以 下简称"《激励计划（草案修订稿）》"）的相关规定，因公司会 计差错更正导致《激励计划（草案修订稿）》首次授予部分第二个 解除限售期及预留授予部分第一个解除限售期已解除限售并上市 流通的限制性股票以及首次授予部分第三个解除限售期及预留授 予部分第二个解除限售期的尚未解除限售的限制性股票均不符合 解除限售的条件，公司计划对前述限制性股票以21.638元/股的价 格进行回购注销并办理相关手续。公司将于回购注销完成后履行 工商变更登记等相关减资程序。 二、需债权人知晓的相关信息 公司本次回购注销部分限制性股票将涉及注册资本减少，根 据《中华人民共和国公司法》（以下简称"《公司法》"）等相关 法律、法规和《公司章程》规定，公司特此通知债 ...

Group 1: Financial Performance - The fair value change income from investment properties for 2024 reached 0.28 billion [2] - As of May 20, 2025, the company's orders on hand amounted to 9.15 billion [3] - The number of shareholders as of May 9, 2025, was 52,846 [3] - Revenue growth for 2024 is projected to slow to 6.3%, while operating costs increased by 12.5% [8] Group 2: Business Operations - The company has no investment properties [2] - The advanced aviation parts intelligent interconnected manufacturing base project is progressing as planned [6] - The company is actively expanding its business in the commercial aerospace sector [3] - The shipbuilding business accounts for approximately 5% of total operations [4] Group 3: Customer and Market Engagement - The company’s products are applied in key drone models [2] - The company is directly cooperating with COMAC for the domestic large aircraft business [4] - The gross margin for overseas business is 52%, but its revenue share is less than 5% [8] - The company has specific plans for overseas market expansion [7] Group 4: Research and Development - The proportion of R&D personnel with master's degrees or higher has decreased by 8 percentage points [4] - The company plans to continue increasing R&D investment [4] - The company is a qualified supplier for the CJ1000A engine components [8] Group 5: Debt and Financial Health - The asset-liability ratio has exceeded the 50% warning line, but the current ratio remains above 1.8 [4] - Short-term loans have a credit loan proportion of 65%, an increase of 20 percentage points from 2023 [7] - The company does not have plans for significant stock buybacks [6]

Group 1 - The company announced the interest payment for its convertible bonds, "Triangle Convertible Bonds," for the period from May 25, 2024, to May 24, 2025, with a total interest of 15.00 CNY for every 10 bonds [1][5] - The total issuance amount of the convertible bonds is 904.3727 million CNY, with a face value of 100 CNY per bond [2] - The bonds have a six-year term and will pay interest annually, with the principal and final interest paid at maturity [2][4] Group 2 - The coupon rates for the bonds are set at 0.40% for the first year, 1.00% for the second year, 1.50% for the fourth year, 2.50% for the fifth year, and 3.00% for the sixth year [1][2] - The company will redeem all unconverted bonds at 115% of the face value, including the last year's interest, within five trading days after the bond's maturity [2][4] - The credit rating for the company and the "Triangle Convertible Bonds" is AA- with a stable outlook, as per the report from Dongfang Jincheng International Credit Assessment Co., Ltd. [4][5] Group 3 - The interest payment will be made through China Securities Depository and Clearing Corporation Limited, Shenzhen Branch, which will distribute the funds to the designated accounts of bondholders [5][6] - Individual bondholders are responsible for paying a personal income tax of 20% on the interest income, which will be withheld by the payment network at the time of interest payment [6][7] - Foreign institutional investors are temporarily exempt from corporate income tax and value-added tax on the interest income from these bonds until December 31, 2025 [7]

证券代码：300775 证券简称：三角防务 公告编号：2025-068 债券代码：123114 债券简称：三角转债 西安三角防务股份有限公司 关于可转换公司债券 2025 年付息的公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 特别提示： 1、"三角转债"将于2025年5月26日按面值支付第四年利息， 每10张三角转债（面值1,000.00元）利息为15.00元。 2、债权登记日：2025年5月23日（星期五） 3、除息日：2025年5月26日（星期一） 4、付息日：2025年5月26日（星期一） 5、三角转债的票面利率为第一年0.40%、第二年0.60%、第三 年1.00%、第四年1.50%、第五年2.50%、第六年3.00%。 6、三角转债本次付息的债权登记日为2025年5月23日，凡在 2025年5月23日（含）前买入并持有本期债券的投资者享有本次派发 的利息，2025年5月23日卖出本期债券的投资者不享有本次派发的利 息。 7、下一付息起息日：2025年5月25日 8、下一付息期利率：2.50% 西安三角防务股份有限公司（以下简称"公司"）于20 ...

Core Insights - The article highlights the achievements of Fan Daidi, a prominent figure in the biotechnology sector, who has transitioned from academia to becoming a billionaire entrepreneur through her innovations in collagen production [1][10]. Group 1: Background and Education - Fan Daidi was born into a rural family in Shaanxi and aspired to be a doctor but shifted to chemical engineering due to vision issues [5]. - She became the first female PhD in China's bio-chemical engineering field and returned to Northwest University to start her research career with limited funding [5][6]. Group 2: Innovations and Business Development - In 2000, she successfully produced human-like collagen using genetic engineering, leading to the first patent in this area in China [7]. - This innovation addressed issues related to animal-derived collagen, such as viral risks and immune rejection, and laid the foundation for her company, Juzi Biotechnology [7][8]. Group 3: Company Performance - Juzi Biotechnology achieved over 10 billion yuan in cumulative sales by 2022, establishing itself as a leader in the collagen market [8]. - The company's revenue surged from 900 million yuan in 2019 to 5.5 billion yuan in 2024, with net profits increasing from 550 million yuan to 2.06 billion yuan during the same period [14]. Group 4: Personal and Professional Identity - Fan Daidi holds significant stakes in Juzi Biotechnology and another company, Triangle Defense, with a combined market value of approximately 443 billion yuan [10][13]. - Despite her wealth, she continues to serve as a strict mentor at Northwest University, balancing her roles as an academic leader and a successful entrepreneur [16][17].

【大河财立方 记者 夏晨翔】近日，一则"西北大学新任副校长范代娣，持股市值达443亿元，晋升新一 任陕西首富"的消息引起广泛关注。 范代娣与丈夫严建亚共同打造的商业版图逐渐浮出水面，叠加其学术身份，瞬间成为舆论焦点。 西北大学官网显示的范代娣简历 西北大学官网显示，2025年4月，范代娣出任西北大学党委委员、常委、副校长。 在商业领域，范代娣与丈夫严建亚二人通过掌控巨子生物（02367.HK）和三角防务（300775.SZ）两家 上市公司，以及在产业链上下游的深入布局，已构建起横跨生物科技与国防军工的资本矩阵。 2000年，范代娣与严建亚在西安高新区共同创立了巨子生物。2022年11月，巨子生物在港交所主板上 市，成为"胶原蛋白第一股"。 在招股书中，范代娣为巨子生物联合创始人、执行董事兼首席科学官；其丈夫严建亚担任法定代表人、 董事长及总经理；女儿严钰博则担任巨子生物的董秘一职。 值得一提的是，2007年，西北大学与巨子生物共同组建陕西省生物材料与发酵工程技术研究中心，主要 研发方向为生物产品的发酵中试放大技术、生物医用材料的研究与开发、组织工程的研究与开发等。 组建时，身为西北大学化工学院副院长的范代娣兼 ...

Group 1 - Baidu Maps has been criticized for embedding ads that affect driving safety, with users reporting that ads obstruct navigation instructions, potentially leading to dangerous situations [1] - The advertising collaboration for Dongpeng Drink on Baidu Maps is expected to exceed 10 million RMB, raising concerns about compliance with internet advertising regulations [1] Group 2 - Hema has been officially sentenced for selling counterfeit L'Oreal and Estée Lauder products, with the main supplier facing a five-year prison term and the total amount involved being 3.22 million RMB [4] - Initially, Hema denied the allegations but later softened its stance as regulatory authorities intervened, leading to some consumer compensation [4] Group 3 - Kudi Coffee has announced an extension of its store subsidy policy until the end of 2028, introducing additional support for stores facing high rent and low sales volume [6] - The new policy aims to lower profitability thresholds in lower-tier markets and encourage franchisees to open stores in key business districts [6] Group 4 - The daughter of Jin Gui Zi achieved sales exceeding 10 million RMB in 30 days through live streaming, responding to criticisms about leveraging her mother's fame [7] - Data indicates that her Douyin account had a total sales volume of 1 million to 2.5 million RMB from 13 live streams [7] Group 5 - The new vice president of Northwest University, Fan Dai Di, has become the richest person in Shaanxi with a net worth exceeding 45.7 billion RMB, primarily from holdings in two listed companies [10][11] - Fan Dai Di is noted for her contributions to collagen protein research and the establishment of a biotechnology company [10] Group 6 - The US and China have announced a significant reduction in tariffs, with US tariffs on Chinese goods dropping from 145% to 30% and Chinese tariffs on US goods decreasing from 125% to 10% over the next 90 days [13] - This temporary agreement is seen as a potential easing of tensions between the two countries, with global stock markets reacting positively [13] Group 7 - A report indicates that the application rate of AI in Chinese workplaces is as high as 93%, significantly above the global average, with half of the users applying AI tools regularly [16] - However, there are concerns about misuse of AI, with a high percentage of Chinese respondents admitting to inappropriate use of AI tools for sensitive data [17]

Group 1 - The core viewpoint of the article highlights the rapid growth and significant market presence of Juzhi Biotechnology, which has become the largest beauty and skincare company in Hong Kong with a market capitalization exceeding 700 billion HKD [2] - The company achieved a remarkable gross profit of 4.5 billion CNY and a gross profit margin of 82.09%, earning the title of "medical beauty leader" [2] - The family of Fan Daidi has a strong influence on the company's management, with several key executives being relatives, indicating a concentrated control over the company's operations [2] Group 2 - Juzhi Biotechnology's performance has significantly boosted the wealth of Fan Daidi and her husband Yan Jianya, making them the new richest individuals in Shaanxi with a holding market value of 457 billion CNY [2][9] - The company has shown impressive revenue growth, with projected revenues of 3.524 billion CNY and 5.539 billion CNY for 2023 and 2024, respectively, alongside net profits of 2.947 billion CNY and 4.547 billion CNY [4] - The couple's wealth explosion began in 2022 with the IPO of Juzhi Biotechnology, which raised 4.6 billion HKD and distributed 2.3 billion HKD in dividends, with the family expected to receive 1.3 billion HKD [4] Group 3 - The family's investment strategy includes diversifying into sectors such as medical beauty, aerospace, and new materials, indicating a long-term vision for capital growth [2] - Yan Jianya has established a reputation as a prominent investment operator in the regional capital market, actively participating in various investment projects [5][6] - The couple's investment activities extend to the establishment of new companies and partnerships, such as the creation of Xi'an Santrong Aviation Technology Co., which received significant investment from local state-owned enterprises [7][8]

Core Viewpoint - The article discusses the rapid growth and wealth accumulation of the couple Fan Daidi and Yan Jianya, who have successfully positioned themselves in the beauty and aerospace industries through their company, Juzhi Biological, which has become a leading player in the Hong Kong stock market. Group 1: Company Performance - Juzhi Biological has seen a remarkable market performance, becoming the largest beauty and skincare company in Hong Kong with a market capitalization of 883 billion HKD as of May 13 [2] - The company achieved a gross profit of 4.5 billion RMB with a gross margin of 82.09%, earning the nickname "Medical Beauty King" [2] - In 2023 and 2024, Juzhi Biological is projected to achieve revenues of 3.52 billion RMB and 5.53 billion RMB, respectively, with net profits of 2.94 billion RMB and 4.54 billion RMB [15] Group 2: Family Business Structure - The management team of Juzhi Biological includes several family members, such as their daughter Yan Yubo, who holds multiple executive roles [4] - The couple has a significant influence over the company, controlling over 20% of the shares, which allows them to maintain substantial decision-making power [11] Group 3: Wealth Accumulation - The couple's wealth surged following the IPO of Juzhi Biological in November 2022, which has been a catalyst for their financial success [14] - As of May 13, the combined market value of Juzhi Biological and Triangle Defense is close to 1 trillion RMB, positioning them as the new richest couple in Shaanxi [29] Group 4: Investment Strategy - The couple is actively pursuing investments in various sectors, including medical beauty, aerospace, and new materials, indicating a strategic expansion of their business interests [5] - Yan Jianya has been involved in multiple investment initiatives, including a significant personal investment in Baotai Co., which highlights his role as a prominent player in the regional capital market [19][20]

| 证券代码：300775 | 证券简称：三角防务 | 公告编号：2025-067 | | --- | --- | --- | | 债券代码：123114 | 债券简称：三角转债 | | 西安三角防务股份有限公司 关于参加"2025 年陕西辖区上市公司投资者集体接待 日暨 2024 年度业绩说明会"的公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 为促进上市公司规范运作、健康发展，增强上市公司信息透明度， 加强与广大投资者沟通交流，进一步提升投资者关系管理水平，陕西 上市公司协会在陕西证监局指导下，联合深圳市全景网络有限公司举 办"2025年陕西辖区上市公司投资者集体接待日暨2024年度业绩说明 会"。 届时，公司负责人及相关高管人员将通过互动平台与投资者进行 网络沟通和交流，欢迎广大投资者踊跃参加！ 活动时间：2025年5月20日 15:00-17:00 活动地址："全景路演" 网址：http://rs.p5w.net 普遍关注的问题进行回答。 2025 年 5 月 13 日 特此公告。 西安三角防务股份有限公司 董事会 为充分尊重投资者、提升交流的针 ...